Suppr超能文献

人类 CD161 蛋白(NKRP1A/KLRB1)识别 LLT1 蛋白的分子基础。

Molecular basis for LLT1 protein recognition by human CD161 protein (NKRP1A/KLRB1).

机构信息

Laboratory of Biomolecular Science, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.

出版信息

J Biol Chem. 2011 Jul 8;286(27):23823-30. doi: 10.1074/jbc.M110.214254. Epub 2011 May 13.

Abstract

Human Th17 cells express high levels of CD161, a member of the killer cell lectin-like receptor (KLR) family (also referred to as NK receptor-P1A (NKRP1A) or KLRB1), as a representative marker. CD161 is also expressed on natural killer (NK) cells and NKT cells. Lectin-like transcript 1 (LLT1), another KLR family member, was recently identified as a ligand for CD161. This interaction may play pivotal roles in the immunomodulatory functions of Th17 cells as well as those of NK and NKT cells. However, the molecular basis for the interaction is poorly understood. Here we show that the extracellular domain of CD161 bound directly to LLT1 with a K(d) of 48 μM and with the fast kinetics typical of cell-cell recognition receptors. Mutagenesis revealed that the similar membrane-distal β-sheet and loop regions of both CD161 and LLT1 were utilized for the binding, and notably, these regions correspond to the ligand-binding sites for major histocompatibility complex (MHC)-recognizing KLRs. Furthermore, we found a pair of detrimental mutations for both molecules that restored the binding. These results reveal a new template model for the recognition mode between the KLR family members and provide insights into the molecular mechanism underlying Th17/NK/NKT-mediated immune responses.

摘要

人 Th17 细胞表达高水平的 CD161,CD161 是杀伤细胞凝集素样受体 (KLR) 家族的成员(也称为 NK 受体-P1A (NKRP1A) 或 KLRB1),作为代表性标志物。CD161 也在自然杀伤 (NK) 细胞和 NKT 细胞上表达。另一个 KLR 家族成员,凝集素样转录本 1 (LLT1),最近被鉴定为 CD161 的配体。这种相互作用可能在 Th17 细胞以及 NK 和 NKT 细胞的免疫调节功能中发挥关键作用。然而,这种相互作用的分子基础了解甚少。在这里,我们表明 CD161 的细胞外结构域以 48 μM 的 K(d)直接与 LLT1 结合,具有细胞间识别受体的快速动力学特征。突变分析表明,CD161 和 LLT1 的类似膜远β-片层和环区都用于结合,值得注意的是,这些区域对应于主要组织相容性复合体 (MHC)-识别 KLR 的配体结合位点。此外,我们发现这两个分子都有一对有害突变,恢复了结合。这些结果揭示了 KLR 家族成员之间识别模式的新模板模型,并为 Th17/NK/NKT 介导的免疫反应的分子机制提供了深入了解。

相似文献

5
LLT1-CD161 Interaction in Cancer: Promises and Challenges.LLT1-CD161 相互作用在癌症中的应用:前景与挑战。
Front Immunol. 2022 Feb 4;13:847576. doi: 10.3389/fimmu.2022.847576. eCollection 2022.

引用本文的文献

1
Immunobiology roles of the human CD161 receptor in T cells.人类CD161受体在T细胞中的免疫生物学作用。
Front Immunol. 2025 Aug 14;16:1648305. doi: 10.3389/fimmu.2025.1648305. eCollection 2025.
10
LLT1-CD161 Interaction in Cancer: Promises and Challenges.LLT1-CD161 相互作用在癌症中的应用:前景与挑战。
Front Immunol. 2022 Feb 4;13:847576. doi: 10.3389/fimmu.2022.847576. eCollection 2022.

本文引用的文献

2
Characterization of alternatively spliced transcript variants of CLEC2D gene.CLEC2D 基因剪接转录变体的特征。
J Biol Chem. 2010 Nov 12;285(46):36207-15. doi: 10.1074/jbc.M110.179622. Epub 2010 Sep 14.
9
PILAR is a novel modulator of human T-cell expansion.PILAR是一种新型的人类T细胞扩增调节剂。
Blood. 2008 Aug 15;112(4):1259-68. doi: 10.1182/blood-2007-12-130773. Epub 2008 Jun 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验